Liã Bárbara Arruda

Dr. Liã Bárbara Arruda

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
NKNathan Kapata
Nathan Kapata
CIChikwe Ihekweazu
Chikwe Ihekweazu
FNFrancine Ntoumi
Francine Ntoumi
TRTajudeen Raji
Tajudeen Raji
PCPascalina Chanda-Kapata
Pascalina Chanda-Kapata
AZAlimuddin Zumla
Alimuddin Zumla

28 August 2020 in Antimicrobial Resistance & Infection Control
Verified
Journal Article
Open access
PDF file
LELinzy Elton
Linzy Elton
MTMargaret J. Thomason
Margaret J. Thomason
JTJohn Tembo
John Tembo
Thirumalaisamy P. VelavanThirumalaisamy P. Velavan
Thirumalaisamy P. Velavan
SPSrinivas Pallerla
Srinivas Pallerla
TCthe PANDORA-ID-NET consortium
the PANDORA-ID-NET consortium
Background: Antimicrobial resistance (AMR) is of growing concern globally and AMR status in sub-Saharan Africa (SSA) is undefined due to a lack of real-time data recording, surveillance and regulation. World Health Organization (WHO) Joint External Evaluation (JEE) reports are voluntary, collaborative processes to assess country capacities and preparedness to prevent, detect and rapidly respond to public health risks, including AMR. The data from SSA JEE reports were analysed to gain an overview of how SSA is working towards AMR preparedness and where strengths and weaknesses lie. Methods: SSA country JEE AMR preparedness scores were analysed. A cumulative mean of all the SSA country AMR preparedness scores was calculated and compared to the overall mean SSA JEE score. AMR preparedness indicators were analysed, and data were weighted by region. Findings: The mean SSA AMR preparedness score was 53% less than the overall mean SSA JEE score. East Africa had the highest percentage of countries reporting having AMR National Action Plans in place, as well as human and animal pathogen AMR surveillance programmes. Southern Africa reported the highest percentage of countries with training programmes and antimicrobial stewardship. Conclusions: The low mean AMR preparedness score compared to overall JEE score, along with the majority of countries lacking implemented National Action Plans, suggests that until now AMR has not been a priority for most SSA countries. By identifying regional and One Health strengths, AMR preparedness can be fortified across SSA with a multisectoral approach.

1 March 2020 in The Lancet Planetary Health
Verified
Journal Article
Open access
RKRichard Kock
Richard Kock
WKWilliam B Karesh
William B Karesh
FVFrancisco Veas
Francisco Veas
Thirumalaisamy P. VelavanThirumalaisamy P. Velavan
Thirumalaisamy P. Velavan
DSDavid Simons
David Simons
AZAlimuddin Zumla
Alimuddin Zumla

24 April 2021 in Annals of Clinical Microbiology and Antimicrobials
Verified
Journal Article
Open access
PDF file
LALiã Bárbara Arruda
Liã Bárbara Arruda
Najmul HaiderNajmul Haider
Najmul Haider
AOAyodeji Olayemi
Ayodeji Olayemi
DSDavid Simons
David Simons
DEDeborah Ehichioya
Deborah Ehichioya
RKRichard Kock
Richard Kock
Lassa fever (LF), a zoonotic illness, represents a public health burden in West African countries where the Lassa virus (LASV) circulates among rodents. Human exposure hinges significantly on LASV ecology, which is in turn shaped by various parameters such as weather seasonality and even virus and rodent-host genetics. Furthermore, human behaviour, despite playing a key role in the zoonotic nature of the disease, critically affects either the spread or control of human-to-human transmission. Previous estimations on LF burden date from the 80s and it is unclear how the population expansion and the improvement on diagnostics and surveillance methods have affected such predictions. Although recent data have contributed to the awareness of epidemics, the real impact of LF in West African communities will only be possible with the intensification of interdisciplinary efforts in research and public health approaches. This review discusses the causes and consequences of LF from a One Health perspective, and how the application of this concept can improve the surveillance and control of this disease in West Africa.

19 May 2022 in Annals of Clinical Microbiology and Antimicrobials
Verified
Journal Article
Open access
PDF file
MHMuhammad Hayat Haider
Muhammad Hayat Haider
TMTimothy McHugh
Timothy McHugh
KRKerry Roulston
Kerry Roulston
LALiã Bárbara Arruda
Liã Bárbara Arruda
ZSZahra Sadouki
Zahra Sadouki
SRSaba Riaz
Saba Riaz
Background and objectives: Burn patients are highly susceptible to invasion by multidrug-resistant Gram-negative bacteria (MDR-GNB) through post-burn damage. The prevalence of MDR-GNB isolated from burns patients has increased dramatically in the last decade, representing a serious risk to patients admitted to burns units worldwide. The challenges of managing infected burns patients are exacerbated in poor resource settings. This study was designed to develop a pathway for the rapid diagnosis of multidrug-resistant (MDR) Gram-negative infections and identify the bacterial genes including blaOXA1, blaTEM, and blaSHV encoding ESBLs and blaOXA48, blaKPC, blaNDM, and blaVIM encoding carbapenemases from the patient of post burns infection. Methods: Clinical isolates were collected (August 2017 to August 2018) from Intensive care unit (ICU) of Burn Centre. Antibiotic susceptibility testing and phenotypic detection of ESBLs and carbapenemases was performed by disk diffusion, double disk synergy test (DDST), combination disk test (CDT), and Imipenem + EDTA combined disk test (IMP + EDTA CDT). Polymerase chain reaction (PCR) detection was performed for ESBLs blaOXA1-blaSHV-blaTEM and carbapenemases genes blaOXA48-blaKPC-blaNDM-blaVIM Results: In total, of 170 Gram-negative isolates, 104 (61.2%) were confirmed as multidrug-resistant (MDR); Pseudomonas aeruginosa was found to be the most prevalent 43/104 (41.4%), followed by Klebsiella pneumoniae 17/104 (16.4%), Acinetobacter baumannii12/104 (11.5%), and 6/104 Proteus mirabilis (5.8%). All isolates (100%) were resistant to cefotaxime and ceftazidime, while the meropenem resistance was 58.7%. ESBL and carbapenemase genotypes were found to be associated with higher MAR index (0.65–0.88) and MIC (> 32 µg/ml) values P. aeruginosa was the major ESBL and carbapenemase producer as determined by phenotypic testing and PCR. blaTEM positive isolates among ESBLs producers were predominant 81.8% (27/33), followed by 27.3% blaOXA1 and blaSHV, respectively. blaVIM positive isolates among carbapenemase producers were predominant 47.7% (21/44), followed by 27.3% blaKPC, 20.5% blaOXA48, and 11.4% blaNDM positive isolates. Conclusions: The predominant organism causing burn infections was ESBL and carbapenemase-producing Pseudomonas aeruginosa. There are only limited effective antibiotics against such strains. blaVIM and blaTEM individually and in co-existence with blaKPC, blaOXA48, blaSHV, and blaOXA1 confer antimicrobial resistance in burns patients. Rapid detection of ESBL and carbapenemase genes will inform treatment strategies improving the outcome for post-burn patients in ICU.

1 July 2021 in Mechanisms of Ageing and Development
Verified
Journal Article
Closed access
JFJuliana Ruiz Fernandes
Juliana Ruiz Fernandes
TPThalyta Nery Carvalho Pinto
Thalyta Nery Carvalho Pinto
LPLucas Lopes Piemonte
Lucas Lopes Piemonte
LALiã Bárbara Arruda
Liã Bárbara Arruda
CSCibele Cristine Berto Marques da Silva
Cibele Cristine Berto Marques da Silva
GBGil Benard
Gil Benard